Acepodia vs Smart Immune
Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
49 employees · est. 2016 · Alameda, United States
Smart Immune
Pioneering thymus-empowered T-cell platform to fight cancer and infection
35 employees · est. 2017 · Paris, France
Acepodia is the older company (2016 vs 2017).
Side-by-Side Comparison
| Metric | Acepodia | Smart Immune |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2017 |
| Headquarters | ||
| Headquarters | Alameda, United States | Paris, France |
| Employees | ||
| Employees | 49 | 35 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series D | Grant |
| Total Funding | ||
| Total Funding | $256.00M | $25.30M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Taxonomy | ||
| Taxonomy | AcepodiaClinical-stageCancer Cell ImmunotherapyOff-the-shelfNK CellsAntibody-cell Conjugation +7 | Cell TherapyCAR TImmuno-oncologyNK CellsT CellsImmune Reconstitution +8 |
| Website | ||
| Website | acepodia.com | smart-immune.com |
About Acepodia
Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER," encapsulates its mission. Acepodia leverages its An...
About Smart Immune
Smart Immune is a French biotechnology startup with a mission to revolutionize treatment outcomes for cancer and infectious diseases. Founded in 2017, the company is focused on developing ProTcell, a groundbreaking thymus-empowered T cell progenitor platform. This innovative technology aims to rapid...
Also comparing in this category
Comparing more than these two?
Get Acepodia, Smart Immune and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Acepodia compare?
A PDF of Acepodia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Acepodia with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Acepodia on 11 Sep 2024, and Smart Immune on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
